Pharmacology and Toxicology Department Highlights: October 2021

(October 1, 2021)

Publications

Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary Sites.  Molecular Pharmacology (2021) Online ahead of print. PMID: 34503974


Presentations

"Advances in Inhaled Nanosystem Formulations: Design and Development" at the 2021 American Association of Pharmaceutical Scientists (AAPS) PharmSci 360 Annual Meeting & Exhibition, Heidi Mansour, PhD, RPh

“Advances and Innovation in Peptide Drug Delivery” at the American Chemical Society (ACS) Rocky Mountain Regional Meeting (RMRM), Peptides Session, Heidi Mansour, PhD, RPh 


Kudos

Heidi Mansour, PhD, RPh is the Co-Chair & Co-Organizer of the American Thoracic Society (ATS)  Assembly on Respiratory Structure and Function (RSF), and the Drug/Device Discovery and Development (DDDD) Committee Webinar Technology Development: Translating Innovation from Bench to Bedside: Part 2

The Wondrak laboratory NIH-supported research on ‘Hypochlorous acid (HOCl) and solar UV-induced cancer’ has been featured by NIEHS (NIEHS Extramural Paper of the Month: September 2021): Title of the NIEHS highlight: Topical therapy holds promise for blocking UV-induced skin cancer

Celina Zerbinatti, PhD was featured by University of Arizona Health SciencesFacebook, twitter, instagram for Women in Health Sciences month.